Navigation Links
Research Warns of Overuse of Powerful Class of Antibiotics
Date:4/3/2011

SUNDAY, April 3 (HealthDay News) -- The use of a powerful class of antibiotics called carbapenems has increased dramatically in the United States over the past five years, a new study shows.

The increased use of these drugs -- widely regarded as the last option for treating severe infections caused by multidrug-resistant bacteria -- is cause for concern because carbapenem-resistant bacteria are becoming more common, the researchers said.

Overuse of carbapenem drugs could lead to the reduction of their effectiveness against tough-to-treat infections.

For this study, the researchers analyzed antibiotic use in 110 VA facilities from 2005 to 2009. They found a gradual rise in overall antibiotic use, but major increases in the use of certain types of antibiotics: carbapenems (102 percent); intravenous vancomycin (79 percent); and combinations of penicillin with beta-lactamase-inhibitors (41 percent).

The investigators also found that fluoroquinolones were the most frequently used class across all the VA facilities, accounting for 20 percent of all antibiotic use.

The study was to be presented Sunday at the Society for Healthcare Epidemiology of America (SHEA) annual meeting, in Dallas.

"Use of these antibiotics helps the patient receiving the treatment, but has future consequences for innocent bystanders. The more these drugs are used, the more resistance we see," study author Dr. Makoto Jones said in a society news release.

"In this era of multidrug-resistant organisms, clinicians are placed in a difficult situation," Dr. Steven Gordon, SHEA president, said in the news release. "As treatment outcomes of many bacterial infections are influenced by the timing of appropriate therapy, the increasing presence of resistant organisms triggers broader use of these powerful antibiotics for proven or suspected infections when treating patients in the hospital."

Gordon added that doctors "must always put the patient first in treatment decisions but we must empower effective antibiotic stewardship programs, infection prevention and control efforts, the development of new diagnostic testing to facilitate better treatment decisions as well as support development of new antibiotics."

Because this study was presented at a medical meeting, the data and conclusions should be viewed as preliminary until published in a peer-reviewed journal.

More information

The U.S. Centers for Disease Control and Prevention has more about antibiotics.

-- Robert Preidt

SOURCE: Society for Healthcare Epidemiology of America, news release, April 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. BATTLE researchers identify new biomarkers for EGFR inhibition
2. Pitt-Stanford research suggests aimless proteins crucial to disease
3. New strategic plan for NIH obesity research seeks to curb epidemic
4. Researchers need to engage lesbian, gay, bisexual, and transginder populations in health studies
5. Researchers publish molecular disease model for melanoma
6. Researchers find possible clues to tamoxifen resistance in breast cancer patients
7. UCSF researchers identify promising new treatment for childhood leukemia
8. Research explores link between asthma and smoking
9. Researchers make the leap to whole-cell simulations
10. UT Southwestern research advances fight against kidney cancer
11. Stepchildren relate to stepparents based on perceived benefits, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research Warns of Overuse of Powerful Class of Antibiotics
(Date:1/24/2017)... ... January 24, 2017 , ... Inspiration, Community & Mentorship ... such as the Fordham Institute’s High Stakes for High Achievers offer ... including gifted or high-achieving students as a subgroup and reporting their results separately. ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a three-year project of the ... the European Union (EU), was completed in May 2015. The future definition will require ... used in air, which presents some challenges to establishing traceability to the mass scale. ...
(Date:1/24/2017)... ... 24, 2017 , ... American Family Care (AFC) has opened a new 4,000+ ... for residents in the area. The Bedford clinic will be the nineteenth location opened ... by Dave Adams and Dr. Kristina Orio. Adams and Orio also independently own and ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... A yellow ... lives in the last month. Yellow fever is primarily spread through contact with infected ... community’s focus on how to prevent its spread. , According to multiple health organizations, ...
(Date:1/24/2017)... ... , ... “Speaking With God’s Voice”: a resolute and spirited call for ... author, Louis A. Miraglia, a born-again believer, who spent his years teaching high school ... , “There is little doubt that God Himself prepared me for this study, ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... -- Aptuit, LLC, hat heute den Beginn ... General Hospital (MGH) unter Leitung von Dr. Laurence ... und Validierung neuartiger Targets in gramnegativen Bakterien.  Aptuit erhofft ... Antibiotika bei der Behandlung schwerer Infektionen entgegenwirken können. ... ...
(Date:1/24/2017)... , Jan. 23, 2017 Laboratory Markets ... global use of mass spectrometry in both clinical and ... ,MS analysis, global market size of $6.8 billion and ... next four years, profiles the use of mass spectrometry ... 21 countries. This study investigated growth in the use ...
(Date:1/24/2017)... 2017 Global Market for Pharmaceutical ... A majority of medicines & drugs produced in ... (API), and such processes require alcoholic solvents such as ... of pharmaceutical solvents continues to be concentrated in the ... (APEJ) region as leading API suppliers and ...
Breaking Medicine Technology: